|
Listing of Comments on Draft NIH Human Stem Cell Guidelines Entire Comment Period: 04/23/2009-05/26/2009 |
|
NIH received 49,015 comments by May 26, 2009, the closing date of the comment period, and have compiled these comments on this website. Any comments received via email or mail after the May 26 deadline are not included on this website. In reviewing the comments, NIH determined that 60 comments were inappropriate (i.e., contained SPAM responses or offensive language), and these comments have been excluded from this website. In addition, to protect the identities and personal information of individuals who submitted comments, NIH has removed personally identifiable information from the comments on this website even though individuals consented that the information provided could be made available for public review and posting.
|
Records 1999 - 2098 of 49015
|
| ID | Entry Date | Affiliation | Organization Name |
Organization Address |
Comments | Attachment |
|---|---|---|---|---|---|---|
| 1999 | 04/30/2009 at 08:56:37 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2000 | 04/30/2009 at 09:01:55 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. | |||
| 2001 | 04/30/2009 at 09:04:05 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration's expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health's (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration's Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2002 | 04/30/2009 at 09:10:48 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while mai ntaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. | |||
| 2003 | 04/30/2009 at 09:13:13 PM | Self | I have had diabetes for 49 years. I worked in support of Prop 71 in California and strongly advocate stem cell research. For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2004 | 04/30/2009 at 09:35:02 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner.
|
|||
| 2005 | 04/30/2009 at 09:43:09 PM | Self | As a Type 1 Diabetic, I would like to thank the administration for for the recent lifting of the stem cell research ban. I would also like to request that the NIH Human Stem Cell Guidelines include the eligibility of stem cell research for federal funding. I further request that this funding only be available to non-corporate research institutions (like the JDRF), in order to avoid conflict of interest on the part of the researchers. By actions taken thus far, you have proven that you see the value of further stem cell research. I, therefore, submit that the degree of support given should be taken to the next logical level by allowing federal funding for researching stem cell's potential as a possible cure for Diabetes and many other diseases currently affecting or ending the lives of United States citizens. Thank you. | |||
| 2006 | 04/30/2009 at 09:45:36 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2007 | 04/30/2009 at 09:53:40 PM | Self | Comment Text (please copy and paste into Comments section) For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2008 | 04/30/2009 at 10:04:18 PM | Self | JDRF, as an organization, will provide comments directly to the NIH | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
||
| 2009 | 04/30/2009 at 10:47:47 PM | Self | I wish to express my opposition to the research of human embryonic stem cells for finding a cure for diseases. This is another way of creating a culture of "death" instead of "life" in America. It seems so unnecessary when there has not been even one example of success in prior research of this kind--yet, there are several examples of success in the use of adult stem cells for curing diseases such as Parkinson's, certain cancers, etc. Why are we so adamant about killing human stem cells? The lack of respect and dignity for life just appalls me in this country, knowing America was founded by people who valued it as a gift from God, no matter how small. Maybe our congress should read "Horton and the Who" Dr. Suess book and hear it's underlying message: "A Person's a Person No Matter How Small" This responsibility needs to be taken very seriously if our leaders don't want to someday stand before God with the blood of children on their hands. I'm beginning to feel that God may be taking His hand off America and it will be because we have abandoned Him first. | |||
| 2010 | 04/30/2009 at 10:48:40 PM | Organization | JDRF | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
||
| 2011 | 04/30/2009 at 10:51:54 PM | Self | I oppose everything that has been proposed in the Draft NIH Human Stem Cell Guidelines, as announced in the April 23, 2009 Federal Register Notice. This if immoral! May God have mercy on your souls. | |||
| 2012 | 04/30/2009 at 10:56:16 PM | Self | I do not think that we ought to be required to pay for research that requires ending human life. I would like the policy to state that emborio's are human life and our goveronment will treat them with the respect we treat all human life.3024 | |||
| 2013 | 04/30/2009 at 10:56:41 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. Thank you for helping in THE CURE!!!!!!!! | |||
| 2014 | 04/30/2009 at 11:14:39 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2015 | 04/30/2009 at 11:28:29 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2016 | 04/30/2009 at 11:45:33 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration's expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health's (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration's Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2017 | 04/30/2009 at 11:47:36 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2018 | 04/30/2009 at 11:53:37 PM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2019 | 05/01/2009 at 12:12:19 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. | |||
| 2020 | 05/01/2009 at 12:16:13 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2021 | 05/01/2009 at 12:19:23 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2022 | 05/01/2009 at 12:20:52 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2023 | 05/01/2009 at 12:21:27 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2024 | 05/01/2009 at 12:22:10 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2025 | 05/01/2009 at 12:22:42 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2026 | 05/01/2009 at 12:25:14 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2027 | 05/01/2009 at 12:36:37 AM | Organization | Juvenile Diabetes Research Foundation - San Diego Chptr. | 5665 Oberlin Drive, Suite 106, San Diego, CA. 92121 | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|
| 2028 | 05/01/2009 at 01:31:32 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2029 | 05/01/2009 at 02:25:10 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2030 | 05/01/2009 at 03:07:08 AM | Self | Although I applaud the move in the direction of seeking the approval of the donors before using the embryos for research purposes, I am still unable to support the harvesting of living cells which might some day become another human being. I do not feel that the decision to give and then immediately take life away should be made so casually. | |||
| 2031 | 05/01/2009 at 05:10:52 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2032 | 05/01/2009 at 06:09:24 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. | |||
| 2033 | 05/01/2009 at 06:13:24 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2034 | 05/01/2009 at 06:19:57 AM | Self | It is immoral, selfish & wrong to be using embryonic stem cells in research - especially in light of the recent discovery that adult stem cells provide the same opportunities for research and offer the same possibility to cure some of these devastating diseases. | |||
| 2035 | 05/01/2009 at 06:23:43 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2036 | 05/01/2009 at 06:25:09 AM | I am asking that you reconcider allowing funding for the use of embryos for stem cell research. | ||||
| 2037 | 05/01/2009 at 06:34:48 AM | Self | I have no problem with stem cell research, so this comment my be somewhat different than the others who are opposed to the new proposals. The issue I have is government paying for this research. In a down economic time where everyone is cutting back to get by, the government continues to print and spend money. As a nation, we cannot afford it. Also, if this research has as much potential as those in favor claims, then private companies would be working day and night on stem cells becasue a break though cure would fund any company for over ten years. The fact that most companies (who also do animal testing mind you, so public appearance isn't really a big concern) aren't having anything to do with this, is very telling to me. I like the research idea, but I can't stand the idea of government paying for it. | |||
| 2038 | 05/01/2009 at 06:36:26 AM | Self | I would like to oppose the funding of human embryonic stem cell research by federal funds. It is not necessary nor a good use of taxpayer money.
|
|||
| 2039 | 05/01/2009 at 06:36:47 AM | Self | Adult Stem Cell research has produced many medical successes.It is not necessary or wise to go down the path of killing innocent life for the slim chance that some unknown benefit may appear in the future. Life is precious and should be preserved and protected. In our country, we have always fought for those that could not fight for themselves.Let's not stray from this time honored tradition. | |||
| 2040 | 05/01/2009 at 06:38:46 AM | Self | I oppose the use of federal money for stem cell research on human embryonic stem cells. I don't believe it is necessary that taxpayers' money be used when adult stem cells are doing the job! | |||
| 2041 | 05/01/2009 at 06:42:39 AM | Self | Quite simply a human embryo is a human life. We were all embryos once! Please make sure the guidelines do not provide incentive for or allow the creation of embryos for destruction. There is no such thing as a leftover embryo; a leftover human life. Certainly no American should be forced to pay for the destruction of human life with tax dollars. Especially since embryonic stem cell research has developed no useful therapies. Since the President has openly stated his desire to reduce federal spending it would be far better to fund no research than take tax dollars for this controversial and questionable research. |
|||
| 2042 | 05/01/2009 at 06:46:42 AM | Self | It saddens me greatly that our country is taking radical steps and moving away from protecting life, which God creates... It has already been stated by those in medical research that that adult stem cell research and such is more beneficial so why are we taking such drastic steps to squash the lives of the unborn??? As an Amercian citizen, I am appalled at how our government is taking such steps adn moving away from how our forefathers began this country. We must respect and protect ALL OF LIFE, especially the unborn, defenseless innocent lives of babies. How sad that out country is trying to play god instead of being, one nation under God. | |||
| 2043 | 05/01/2009 at 06:47:41 AM | Self | For over 20 years Adult Stem Cells have proven to work. Imbronic Stem Cells have never worked, and the only thing we know with absolute certainy, is that we must kill a baby to even try to make them work. |
|||
| 2044 | 05/01/2009 at 06:49:59 AM | Self | On March 9, 2009 President Barack Obama issued an executive order that overturned President Bush's policy and opened the floodgates for funding more embryonic stem cell research (ESCR) that creates an incentive to create and destroy human embryos. President Obama designated the National Institutes of Health (NIH) to draft guidelines for distributing funds for this research. On April 23, NIH officially posted draft guidelines to open federal funding for research on human embryonic stem cells. What these guidelines do is send our tax dollars to experiment on stem cells taken from human embryos that supposedly are "leftover" from in vitro fertilization. Instead of promoting the adoption of these human embryos, these draft guidelines would require their death. This is a human rights issue. These humans, in their smallest but alive form must be protected by the same Constitution that protects us all. These humans, like all humans, deserve the right to life, liberty and the pursuit of happiness. Yes Life must happen first before ALL else. Without life, there is no liberty or pursuit of happiness. Do not kill one human embroy for science. In effect, you are reducing a human life to a economic commodity to be bought and sold and killed. Slavery is illegal, so should be destroying human embryos. I will pray we wake up and protect, not destroy, human life. | |||
| 2045 | 05/01/2009 at 06:52:21 AM | Self | Please do not use my tax dollars for human embryonic stem cell research. I believe that this is unnecessary given that adult stem cell research has been so successful. Thank you. | |||
| 2046 | 05/01/2009 at 06:53:13 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2047 | 05/01/2009 at 06:58:45 AM | Self | As a person that values human life, liberty, and freedoms that America has laid as our foundation, I find this new turn of national law and addendum to be of the highest disregard of our national heritage. It is against family and children that it is deemed idealogical to use embryos for stem cell research. I am not against trying to find cures for illnesses, but I do have a concern when unborn life is at risk. We must first look to the one who is in charge of our healing and obey and believe that he has taken our sickness and disease when he died upon that cross. Please do not overturn what President Bush put in place for the protection of our unborn children, but use it and honor life and family. I do not think it wise to use tax dollars or other funding to destroy life of unborn children. Children are the gift of God himself and they should be cared for and nurtured not murdered for the purpose of finding cures for illnesses that can be found elsewhere.
|
|||
| 2048 | 05/01/2009 at 07:01:26 AM | Self | We are opposed to President Obama's executive order overturning President Bush's policy on embryonic stem cell research. Why should our tax money be used on this, when such funds and efforts focused on adult stem cell research would prove to be far more beneficial? | |||
| 2049 | 05/01/2009 at 07:01:40 AM | Self | April 23, NIH officially posted draft guidelines to open federal funding for research on human embryonic stem cells. These guidelines send our tax dollars to experiment on stem cells taken from human embryos that supposedly are "leftover" from in vitro fertilization. Instead of promoting the adoption of these human embryos, these draft guidelines would require their death. Our declaration of independence declares that all people have right to life. We treat embryos like plantation holders treated slaves or nazi's treated jews. This is barbaric! | |||
| 2050 | 05/01/2009 at 07:01:59 AM | Self | please do not allow embroyonic stem cells to be used for any research. It is immoral and wrong. It is not even needed. STem cell; research can be done without using embroyos. | |||
| 2051 | 05/01/2009 at 07:02:13 AM | Self | I strongly oppose the use of research on stem cells, and believe it is morally wrong. | |||
| 2052 | 05/01/2009 at 07:04:34 AM | Self | Dear Sirs; I'm writing to voice my oposition to Presitent Barak Obama's executive order lifting the current bans on Fetal Stem Cell Research. I support the bans which were put in place through the Dickey-Wicker ammendment and desire that they should be upheld. Fetal Stem Cell Research, as it will be conducted under President Obama's new guidelines, harkens back to the research on humans conducted during the era of Nazi Germany. I believe this is a road as Americans we should not travel down. I am sincerely; | |||
| 2053 | 05/01/2009 at 07:07:07 AM | Self | Rationalization will be the death of us. We rationalize anything in the name of "the common good" Killing human embryos for research is just another example in a long line of "rationalizations" to kill the most innocent of us all. The unborn. Please take a stand for life and DO NO HARM! Stop rationalizing away the life of the unborn. Reject this latest assault on life! |
|||
| 2054 | 05/01/2009 at 07:07:11 AM | Self | I oppose the Draft NIH Human Stem Cell Guidelines because overwhelmingly the most successful research has been with adult stems cells, not embryonic, and you don't have to destroy a living embryo in the adult stem cell process. The only reason this research with embryonic stem cells is pushed is because the inventors are after the money for patenting the lines. When adult stem cells are used, there is no patent involved. I think the government should protect all human life instead of find ways to end it. | |||
| 2055 | 05/01/2009 at 07:10:06 AM | Self | My wife and I oppose use of federal funds for research on human embryonic stem cells. In doing so you are ending the life of a person. | |||
| 2056 | 05/01/2009 at 07:11:17 AM | Self | I am morally and ethically opposed to using embryonic stem cells for medical and research purposes. When adult stem cells have proven successful and the success of embryonic stem cells is suspect – why would you chose to experiment with embryonic stem cells at the destruction of a human life? | |||
| 2057 | 05/01/2009 at 07:12:10 AM | Self | I am opposed to the proposal to create and destroy human embryos for research. Please reconsider the guidleines that allow for the destruction of viable embryos. An embryo is an unborn life and worthy of protection. Thank you. | |||
| 2058 | 05/01/2009 at 07:14:23 AM | Self | Please do not allow the use of embryos for stem cell research. Embryonic stem cells have not proven to be beneficial, whereas stem cells from umbilical cords and adult stem cells have shown great promise. There is no need to destroy human life to study stem cells. | |||
| 2059 | 05/01/2009 at 07:15:32 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. | |||
| 2060 | 05/01/2009 at 07:16:36 AM | Self | The government is forcing us to fund abortion. Now, it wants us to fund something to promote abortion. Then when it uses all the funds to support and promote an evil like abortion, it is going to rub our noses in it by creating embryos in order to kill them. Enough is enough. There are workable alternatives that do not require creating babies and then killing them. | |||
| 2061 | 05/01/2009 at 07:20:09 AM | Organization | Gospel of Grace Ministry | "Studies of human embryonic stem cells may yield information about the complex events that occur during human development." Studies that involve the death 7562of fertilized human being embryos in the name of research will absolutely bring the curse of God upon this nation. |
||
| 2062 | 05/01/2009 at 07:21:27 AM | Self | Quote "The purpose of these draft Guidelines is to implement Executive Order 13505, issued on March 9, 2009, as it pertains to extramural NIH-funded research, to establish policy and procedures under which NIH will fund research in this area, and to help ensure that NIH-funded research in this area is ethically responsible, scientifically worthy, and conducted in accordance with applicable law." As a United States of America citizen, that values the dignity of human life, I find the funding of embryonic stem cell research an improper and wasteful use of tax dollars. The research and results regarding adult stem cells has shown great promise and does not dishonor human life in the ways that embryonic stem cell research does. Please take a harder look at the scientific evidence, embryonic stem cell research is neither worthy nor ethically responsible. |
|||
| 2063 | 05/01/2009 at 07:21:46 AM | Self | I am very much against embryonic stem cell research. This is the taking and killing of innocent children that have no choice. This is against the laws of God and He will judge our country for the things we have done. | |||
| 2064 | 05/01/2009 at 07:25:08 AM | Self | I oppose federal funding for embryonic stem cell research. This involves taking a life and invites a culture of death. Instead, we should be encouraging research for adult stem cells as they have already proven to provide medical treatments for various conditions. With the availability of using adult stem cells and the already promising research, there is no reason to pursue embyonic stem cells which take a life and open the door to cloning of human beings, the making of human-animal hybrids, the manipulation of germ lines, and the like. |
|||
| 2065 | 05/01/2009 at 07:25:12 AM | Self | comments on the Draft NIH Human Stem Cell Guidelines Please do not allow our tax money to be used to farm unwanted fetus for stem cell research. It is noted that stem cell research can be done without the use of embroyonic cells. |
|||
| 2066 | 05/01/2009 at 07:26:19 AM | Self | These embryos are human beings. This lack of respect for the human being is a mistake. Who is responsible for protecting the rights of those who cannot speak? We have promising research from adult stem cells. This is the ethical approach. If we don't accept the intrinsic value of human life, we are on a slope to terrifying consequences, and the Nazi genocide will pale in comparison.
|
|||
| 2067 | 05/01/2009 at 07:26:53 AM | Self | To date we have 73 certifiable positive results towards the treatment and cures from ADULT stem cell research and none, absolutely zero,from embryonic stem cell research. In fact, results from embryonic stem cells have been from cancerous and/or rejected by humans. Taxpayers have funded millions of dollars towards embryonic research to discover what has already been verified in previous private researches. This, most certainly, does not justify the funding toward the creation and death of more embryos. The government should not invest in this business at all. | |||
| 2068 | 05/01/2009 at 07:28:38 AM | Self | Human stem cells as a source of research material is ethically unacceptable as a viable human being must be killed in order to "harvest" the necessary cells. In the past 25 plus years of research using such a source of stem cells, no useful medical treatments have been found. Conversely, adult stem cells can be obtained in an ethically acceptable manner. Adult stem cells have been used successfully to treat 70 plus disorders. What more needs be said? | |||
| 2069 | 05/01/2009 at 07:28:54 AM | Self | I oppose sending my tax dollars to experiment on stem cells taken from human embryos that supposedly are "leftover" from in vitro fertilization. These embryos shoud be promoted bia adoption instead of requiring ther 'death.' | |||
| 2070 | 05/01/2009 at 07:30:45 AM | Self | I am opposed to the proposed guideline changes. Do not play with human life. I have a child with autism, but advances made at the expense of the life of others is not worth it. The end does not justify the means. | |||
| 2071 | 05/01/2009 at 07:31:02 AM | Self | We OPPOSE use of federal funds for research on human embryonic stem cells. Over 70 diseases are being treated today with ADULT stem cells. Please put tax dollars towards programs that work. Thank you. |
|||
| 2072 | 05/01/2009 at 07:31:34 AM | Self | There is no evidence that embryonic stem cell research has produced any positive news for the treatment of diseases or injuries. This is in addition to the ethical problem of killing a human embryo. On the other side, the adult stem cell research has proven over and over again that it can be very helpful in the treatment of injuries and diseases (I believe the number now is over sixty). Why would anyone even consider killing a human embryo or creating one to kill when all the evidence points in the opposite direction? | |||
| 2073 | 05/01/2009 at 07:31:49 AM | Self | Please do not allow stem cell from infants , adult are fine, using infants or preborn is pure murder. President Bush was right Obama is so totally WRONG | |||
| 2074 | 05/01/2009 at 07:31:51 AM | Self | President Barack Obama has issued an executive order that overturned President Bush's stem cell policy and opened the floodgates for funding more embryonic stem cell research (ESCR) that creates an incentive to create and destroy human embryos. The NIH guidelines send our tax dollars to experiment on stem cells taken from human embryos that supposedly are "leftover" from in vitro fertilization. Instead of promoting the adoption of these human embryos, these draft guidelines would require their death. | |||
| 2075 | 05/01/2009 at 07:32:28 AM | Self | We the people would prefer that our tax money go to the specifically defined purposes outlined in the constitution. Those pertain to Life Liberty and Pursuit of Happiness. We should not spend any tax dollars for things of this nature. We need to protect the unborn, not exploit them at the inception of life or direct what other countries do. Please don't use our money for this purpose. Please step back and realize we are unable to sustain the huge appitite the government has to control everything including the air we breath and our thoughts based on the Bible(with our own hard earned money). We are a Christian nation no matter what Pres. Obama says and need to return to the philosophies that made this country great. |
|||
| 2076 | 05/01/2009 at 07:32:34 AM | Self | I do not want my tax dollars spent on embryonic stem cell research, more research should be done with adult stem cells, this has shown the most promise. To date nothing has come from embryonic stem cell research, except death. | |||
| 2077 | 05/01/2009 at 07:32:52 AM | Self | As you know, President Bush's policy was to allow funding for research that involved embryonic stem cells taken from human embryos so long as the cells were obtained on or prior to August 9, 2001. Since then, the government has funded research on over 22 stem cell lines. President Bush's policy erected a wall and did not encourage the further killing of human embryos for their cells. However, on March 9, 2009 President Barack Obama issued an executive order that overturned President Bush's policy and opened the floodgates for funding more embryonic stem cell research (ESCR) that creates an incentive to create and destroy human embryos. President Obama designated the National Institutes of Health (NIH) to draft guidelines for distributing funds for this research. Last week, April 23, NIH officially posted draft guidelines to open federal funding for research on human embryonic stem cells. What these guidelines do is send our tax dollars to experiment on stem cells taken from human embryos that supposedly are "leftover" from in vitro fertilization. Instead of promoting the adoption of these human embryos, these draft guidelines would require their death. Thus, we oppose such madness from this socialist regime. We say NO to these guidelines. |
|||
| 2078 | 05/01/2009 at 07:33:07 AM | Self | I AM VEHEMENTLY AGAINST USING FEDERAL FUNDS FOR ANY FORM OF RESEARCH USING HUMAN EMBRYONIC STEM CELLS ("LEFT OVER" OR PRODUCED FOR THAT PURPOSE). | |||
| 2079 | 05/01/2009 at 07:33:18 AM | Self | I oppose the use of my tax to perform human embryo stem cell research for two reasons. First, adult stemm cells have shown success whereas, embryo stem cells have not. Second and more important, I totally oppose the destruction of human life to perform scientific research. This amounts to a barbarian action that basically says that some human life can be destroyed to help others. I absolutely oppose my tax dollars being used in this way. | |||
| 2080 | 05/01/2009 at 07:33:37 AM | Self | Adult stem cells already are proving their ability to help in finding cures to many illnesses that plague man. Embyonic stem cells have not. The destruction of these cells is another step in the downward spiral in man's immorality and demise. There will be a day when each of us will have to stand before a rightious God to answer for our sins. I wouldn't want to have to try to give a defense for the destruction of innocent life whether it is abortion or the harvesting of embryonic cells. | |||
| 2081 | 05/01/2009 at 07:33:58 AM | Self | Please stop the killing of the unborn to satisfy your greed. | |||
| 2082 | 05/01/2009 at 07:34:15 AM | Self | I am opposed to federal funding for embryonic stem cell research. ESR has shown no benefit in treating any illness, whereas adult stem cells have been used successfully. | |||
| 2083 | 05/01/2009 at 07:35:15 AM | Self | I am opposed to research using human embryonic stem cells that were derived from embryos created by in vitro fertilization (IVF) for reproductive purposes. Please promote the adoption of these human embryos/children and focus on non-embryonic human adult stem cells. | |||
| 2084 | 05/01/2009 at 07:35:41 AM | Self | You notice states - "These draft Guidelines would allow funding for research using human embryonic stem cells that were derived from embryos created by in vitro fertilization (IVF) for reproductive purposes and were no longer needed for that purpose." I oppose using embryonic stem cells in any case because every embryo is a life at conception. How can we say one life is less worthy than another? If you allow this, then we're headed for a moral and ethical downfall in our nation. It can be equated to Hitler's goal to annihilate the Jews because according to him, they were of lesser value. Every life is worthy of dignity. | |||
| 2085 | 05/01/2009 at 07:36:00 AM | Self | As a tax payer I oppose the federal funding for research on human embryonic stem cells. | |||
| 2086 | 05/01/2009 at 07:36:26 AM | Self | We feel that Embryonic stem cell research is a moral issue that should not be broached. It is our understanding that adult stem cell research is the area that has provided real benefit to the health field. Embryonic stem cell research has always been available, but the private sector has not pursued it because it has not been shown to produce the results that adult cell research has produced, due to the unpredictability of cell replication. Please do not use our tax dollars to perform research on embryonic stem cells. | |||
| 2087 | 05/01/2009 at 07:37:44 AM | Self | We ask that you please consider the science; it has been made plain that adult stem cells prove to hold great potential and have actually proved useful both in research and in application. Please provide funding for adult stem cell research instead of embryonic stem cell research, which has given no indication of usefulness whatsoever. Please, please, follow the science not the rhetoric. | |||
| 2088 | 05/01/2009 at 07:38:14 AM | Self | I object to using my taxpayer dollars to perform what I believe to be research that kills a human being. My greater concern is that this research, if successful, will lead to an industry to manufacture and kill thousands or millions of embryos to produce medications to help but a few, thus furthering the devaluing of human life. | |||
| 2089 | 05/01/2009 at 07:38:18 AM | Self | I oppose the policy change concerning the funding of embrtoinic stem cell research. The current administration's policy of funding research on "leftover" embryos from fertilization clinics is both immoral and unnecessary. most of the documented benefits from stem cell research comes from adult stem cells. This policy will only encourage the abortion of more unborn children, which should be allowed to grow and if necessary made available to adoption. This policy is destructive to the value of human life here in the US. | |||
| 2090 | 05/01/2009 at 07:39:31 AM | Self | For many Americans with a personal connection to type 1 diabetes, the Administration’s expansion of the federal policy on embryonic stem cell research has renewed our hope for a cure. I am writing today to support the National Institutes of Health’s (NIH) draft guidelines and suggest a change to ensure promising, ethically conducted research currently underway will be eligible for federal funding in the future. The Administration’s Executive Order on stem cell research restored scientific decision-making to its rightful place at the NIH. In these guidelines, the NIH has demonstrated its capacity to formulate a research framework that will unleash the potential of embryonic stem cell research while maintaining the highest safety and ethical standards. I would encourage the NIH, however, to grandfather into this policy stem cell lines that have received federal funding, as well as existing lines that were derived in an ethically-responsible manner according to the best practices at the time. Research on these stem cell lines should be eligible for federal funding so that scientists can maximize the scientific advancements already achieved through research on these lines. Research should be vigorously pursued on all promising stem cell sources that could potentially lead to a cure for type 1 diabetes. While embryonic stem cell research is still in its early stages, this research has already yielded impressive results in our continuing effort to find a cure for type 1 diabetes. Recent research suggests that embryonic stem cells can be differentiated to produce the insulin-producing beta cells that could reverse the course of type 1 diabetes. We do not yet know which stem cell sources may ultimately lead to a cure or be the most clinically useful or practical for patients with type 1 diabetes. It is clear, however, that the more knowledge we gain about embryonic stem cells, the better we can assess the full therapeutic potential of all stem cell sources. These draft guidelines allowing federal funding for embryonic stem cell research using excess embryos from fertility clinics will ensure that this research matures and its potential is more fully realized. I commend the NIH for allowing this important research to expand in a scientifically and ethically appropriate manner. |
|||
| 2091 | 05/01/2009 at 07:41:33 AM | Self | I do not want my tax dollars used to experiment on stem cells taken from human embryos that supposedly are "leftover" from in vitro fertilization. Instead of promoting the adoption of these human embryos, these draft guidelines would require their death. I oppose use of federal funds for research on human embryonic stem cells. We're American's. This is a practice beneath our dignity and humanity as a nation, and it's not below my paygrade to determine that.
|
|||
| 2092 | 05/01/2009 at 07:42:07 AM | Self | none | PLEASE DO NOT LET THIS PASS! April 23, NIH officially posted draft guidelines to open federal funding for research on human embryonic stem cells. What these guidelines do is send your tax dollars to experiment on stem cells taken from human embryos that supposedly are "leftover" from in vitro fertilization. Instead of promoting the adoption of these human embryos, these draft guidelines would require their death. Let's not play God, but choose what is moral, right and ethical following the very foundation of our Great Nation. |
||
| 2093 | 05/01/2009 at 07:44:06 AM | Self | Please note that I oppose funding more embryonic stem cell research (ESCR) that creates an incentive to create and destroy human embryos AND using MY tax dollars to do so. I think I AS AN AMERICAN should have SAY in where MY money goes. There has been significant breakthrough in ADULT stem cell research. Thank you |
|||
| 2094 | 05/01/2009 at 07:44:46 AM | Self | I do not think this would be in the best intrest of the people . Even though other people have said it would . Thank you | |||
| 2095 | 05/01/2009 at 07:44:48 AM | Self | I am very opposed to the killing of "left over" embryos for stem cell research to be funded by me, the taxpayer. I am very pro life and don't condone any killing of children at any stage. I don't want my hard earned money to be spent on something I am very much against. Sincerely, |
|||
| 2096 | 05/01/2009 at 07:44:56 AM | Self | Destroying human life to research ways of curing illnesses is nonsensical. There has been promising research in areas without the need to destroy human life. Lets focus on that research.
|
|||
| 2097 | 05/01/2009 at 07:44:56 AM | Self | I do not agree with these guidelines to send my tax dollars to experiment on stem cells taken from human embryos that are "leftover" from in vitro fertilization. Every human -- from the moment of conception to the moment of natural death is sacred and ought to be treated as such. |
|||
| 2098 | 05/01/2009 at 07:45:37 AM | Self | We think very strongly that embroyonic stem cell research is very wrong and should never be funded by tax payers. obama should not be allowed to use our tax dollars for something so wrong, immoral and contreversial. science has shown that adult stem cell research is much better and much more effective also |